Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-05 @ 8:19 PM
Study NCT ID:
NCT01080027
Status:
COMPLETED
Last Update Posted:
2014-07-31
First Post:
2010-03-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability and Adherence With Rebif® New Formulation in Real Life Settings (STAR)
Sponsor:
Organization:
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
Enrollment Type:
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: